| Product NDC: | 63851-501 |
| Proprietary Name: | RabAvert |
| Non Proprietary Name: | Rabies Vaccine |
| Active Ingredient(s): | & nbsp; Rabies Vaccine |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63851-501 |
| Labeler Name: | Novartis Vaccines and Diagnostics GmbH |
| Product Type: | VACCINE |
| FDA Application Number: | BLA103334 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19971020 |
| Package NDC: | 63851-501-01 |
| Package Description: | 1 KIT in 1 CARTON (63851-501-01) * 1 mL in 1 VIAL, GLASS (63851-511-11) * 1 mL in 1 VIAL, GLASS (63833-765-30) |
| NDC Code | 63851-501-01 |
| Proprietary Name | RabAvert |
| Package Description | 1 KIT in 1 CARTON (63851-501-01) * 1 mL in 1 VIAL, GLASS (63851-511-11) * 1 mL in 1 VIAL, GLASS (63833-765-30) |
| Product NDC | 63851-501 |
| Product Type Name | VACCINE |
| Non Proprietary Name | Rabies Vaccine |
| Dosage Form Name | KIT |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19971020 |
| Marketing Category Name | BLA |
| Labeler Name | Novartis Vaccines and Diagnostics GmbH |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |